Literature DB >> 12971665

The new National Tuberculosis Control Programme in Israel, a country of high immigration.

D Chemtob1, A Leventhal, Y Berlowitz, D Weiler-Ravell.   

Abstract

SETTING: Israel has implemented a new tuberculosis (TB) control programme in response to the rise in the incidence of tuberculosis due to immigration in the last decade. It complies with World Health Organization guidelines, and also includes specific measures addressing the needs of immigrants. We describe the new programme and compare the outcome of treatment prior and after its realisation.
METHODS: Each component of the new strategy was scrutinised, aspects that did not function well were identified and how we contended with these issues is described. Analysis of outcome of treatment was according to WHO/IUATLD definitions.
RESULTS: Better and clearer organisation of TB treatment in all its aspects, including cultural sensitivity, has been obtained. Compliance improved from less than 27% for successful outcome before the new programme to more than 75% after. In addition to the improvement in completion rates, the universal use of directly observed treatment has ensured enhanced adherence.
CONCLUSION: Using legislative, administrative and budgetary measures, as well as clinical guidelines published by the Ministry of Health, the TB infrastructure in Israel has been successfully reorganised. The decision to do so was not only clinically and organisationally justifiable, it is also economically viable.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12971665

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Outcome of hospitalized MDR-TB patients: Israel 2000-2005.

Authors:  D Bendayan; A Hendler; V Polansky; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-23       Impact factor: 3.267

2.  Intestinal granulomatous disease: what is the first call.

Authors:  Alex Guri; Michal Kori; Pearl Herskovitz; Oren Zimhony
Journal:  BMJ Case Rep       Date:  2018-04-19

3.  Tuberculosis in native Israeli Arabs and Jews: trends and treatment outcomes, 1999-2011.

Authors:  H Bishara; D Goldblatt; E Rorman; Z Mor
Journal:  Epidemiol Infect       Date:  2015-04-17       Impact factor: 4.434

4.  A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025.

Authors:  Daniel Chemtob; Dan Gandacu; Zohar Mor; Itamar Grotto; Emilia Anis; Elliot Rosenberg
Journal:  Isr J Health Policy Res       Date:  2017-04-19

Review 5.  Social determinants, ethical issues and future challenge of tuberculosis in a pluralistic society: the example of Israel.

Authors:  N L Bragazzi; M Martini; N Mahroum
Journal:  J Prev Med Hyg       Date:  2020-04-30

6.  Ensuring HIV care to undocumented migrants in Israel: a public-private partnership case study.

Authors:  Daniel Chemtob; Rivka Rich; Neta Harel; Nechama Averick; Eyal Schwartzberg; Israel Yust; Shlomo Maayan; Itamar Grotto; Ronni Gamzu
Journal:  Isr J Health Policy Res       Date:  2019-11-13

Review 7.  Tuberculosis treatment outcomes of non-citizen migrants: Israel compared to other high-income countries.

Authors:  D Chemtob; E Ogum
Journal:  Isr J Health Policy Res       Date:  2020-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.